Timothy M Shannon - Net Worth and Insider Trading
Timothy M Shannon Net Worth
The estimated net worth of Timothy M Shannon is at least $138 Million dollars as of 2024-11-13. Timothy M Shannon is the Director of IDEAYA Biosciences Inc and owns about 2,660,713 shares of IDEAYA Biosciences Inc (IDYA) stock worth over $82 Million. Timothy M Shannon is the Director of Arvinas Inc and owns about 1,733,771 shares of Arvinas Inc (ARVN) stock worth over $46 Million. Timothy M Shannon is also the Director of NextCure Inc and owns about 2,254,442 shares of NextCure Inc (NXTC) stock worth over $3 Million. Besides these, Timothy M Shannon also holds CytomX Therapeutics Inc (CTMX) , Rallybio Corp (RLYB) , Celldex Therapeutics Inc (CLDX) . Details can be seen in Timothy M Shannon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy M Shannon has not made any transactions after 2021-09-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy M Shannon
Timothy M Shannon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy M Shannon owns 6 companies in total, including Arvinas Inc (ARVN) , IDEAYA Biosciences Inc (IDYA) , and NextCure Inc (NXTC) among others .
Click here to see the complete history of Timothy M Shannon’s form 4 insider trades.
Insider Ownership Summary of Timothy M Shannon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARVN | Arvinas Inc | 2021-09-07 | director |
| IDYA | IDEAYA Biosciences Inc | 2019-05-28 | director |
| NXTC | NextCure Inc | 2019-05-13 | director |
 | | 2016-11-29 | director |
| | 2010-09-10 | director |
| | 2021-08-02 | director |
Timothy M Shannon Latest Holdings Summary
Timothy M Shannon currently owns a total of 6 stocks. Among these stocks, Timothy M Shannon owns 2,660,713 shares of IDEAYA Biosciences Inc (IDYA) as of May 28, 2019, with a value of $82 Million and a weighting of 59.93%. Timothy M Shannon owns 1,733,771 shares of Arvinas Inc (ARVN) as of September 7, 2021, with a value of $46 Million and a weighting of 33.16%. Timothy M Shannon also owns 2,254,442 shares of NextCure Inc (NXTC) as of May 13, 2019, with a value of $3 Million and a weighting of 2.52%. The other 3 stocks CytomX Therapeutics Inc (CTMX) , Rallybio Corp (RLYB) , Celldex Therapeutics Inc (CLDX) have a combined weighting of 4.38% among all his current holdings.
Latest Holdings of Timothy M Shannon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IDYA | IDEAYA Biosciences Inc | 2019-05-28 | 2,660,713 | 30.98 | 82,428,889 |
| ARVN | Arvinas Inc | 2021-09-07 | 1,733,771 | 26.31 | 45,615,515 |
| NXTC | NextCure Inc | 2019-05-13 | 2,254,442 | 1.54 | 3,471,841 |
| CTMX | CytomX Therapeutics Inc | 2016-11-29 | 3,244,829 | 1.04 | 3,374,622 |
| RLYB | Rallybio Corp | 2021-08-02 | 2,409,712 | 1.10 | 2,650,683 |
| CLDX | Celldex Therapeutics Inc | 2010-09-10 | 7 | 27.03 | 189 |
Holding Weightings of Timothy M Shannon
Timothy M Shannon Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy M Shannon has made a total of 0 transactions in IDEAYA Biosciences Inc (IDYA) over the past 5 years. The most-recent trade in IDEAYA Biosciences Inc is the acquisition of 400,000 shares on May 28, 2019, which cost Timothy M Shannon around $4 Million.
According to the SEC Form 4 filings, Timothy M Shannon has made a total of 7 transactions in Arvinas Inc (ARVN) over the past 5 years, including 3 buys and 4 sells. The most-recent trade in Arvinas Inc is the sale of 68,798 shares on September 7, 2021, which brought Timothy M Shannon around $6 Million.
According to the SEC Form 4 filings, Timothy M Shannon has made a total of 0 transactions in NextCure Inc (NXTC) over the past 5 years. The most-recent trade in NextCure Inc is the acquisition of 50,000 shares on May 13, 2019, which cost Timothy M Shannon around $750,000.
More details on Timothy M Shannon's insider transactions can be found in the Insider Trading History of Timothy M Shannon table.Insider Trading History of Timothy M Shannon
- 1
Timothy M Shannon Trading Performance
GuruFocus tracks the stock performance after each of Timothy M Shannon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy M Shannon is -1.31%. GuruFocus also compares Timothy M Shannon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy M Shannon within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy M Shannon's insider trading performs compared to the benchmark.
Performance of Timothy M Shannon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.31 | | | | | |
| Relative Return to S&P 500(%) | 4.65 | | | | | |
Timothy M Shannon Ownership Network
Ownership Network List of Timothy M Shannon
Ownership Network Relation of Timothy M Shannon
Timothy M Shannon Owned Company Details
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Timothy M Shannon is the director of Arvinas Inc. Other key executives at Arvinas Inc include Chief Accounting Officer David K Loomis , Chief Medical Officer Ronald Peck , and Chief Financial Officer Sean A Cassidy .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Timothy M Shannon made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 460 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 460 shares. During the past 18 months, 12,082 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,082 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
Timothy M Shannon Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy M Shannon. You might contact Timothy M Shannon via mailing address: C/o Curagen Corp, 555long Wharf Dr. 11th Fl., New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
